Vertex, Parion Collaboration to Advance Development of Potential Therapeutic Strategy for CF, Other Pulmonary Disorders
Cystic Fibrosis, News
Vertex recently announced a collaboration with Parion Sciences with the goal of developing investigational epithelial sodium channel (ENaC) inhibitors as potential therapies for cystic fibrosis (CF) and other pulmonary disorders. CF is ... Read more